Protocol for treatment and research of acute lymphoblastic leukaemia of childhood of the Dutch childhood oncology group
Not Applicable
Completed
- Conditions
- LeukaemiaCancerAcute Lymphoblastic Leukaemia (ALL)
- Registration Number
- ISRCTN21542083
- Lead Sponsor
- Dutch Childhood Oncology Group (Stichting Kinder Oncologie [SKION]) (The Netherlands)
- Brief Summary
2009 Results article in https://pubmed.ncbi.nlm.nih.gov/19747876/ (added 20/08/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 918
Inclusion Criteria
All children with acute lymphoblastic leukaemia from one year (365 days) until 18 years of age, excluding mature B-cell ALL.
Exclusion Criteria
1. Mature B-cell ALL
2. Relapsed ALL
3. Secondary ALL
4. Pretreatment with corticosteroids or cytostatic drugs in the four weeks preceding diagnosis
5. Patient of whom essential diagnostic tests are missing
6. Patients in whom essential parts of therapy were not given
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method